Asset Purchase Agreement between VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS LUXEMBOURG SARL, and IGI LABORATORIES, INC. dated as of September 30, 2014 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • October 1st, 2014 • Igi Laboratories, Inc • Biological products, (no disgnostic substances) • New York
THIS ASSET PURCHASE AGREEMENT is entered into as of September 30, 2014 by and between Valeant Pharmaceuticals North America, LLC, a Delaware limited liability company and Valeant Pharmaceuticals Luxembourg SARL, a Luxembourg limited liability company (together, “Seller”), and IGI Laboratories, Inc., a Delaware corporation (“Purchaser”).
